M&A: Page 16
-
Haemonetics unveils back-to-back divestitures of blood supply assets
The company saw a 25% to 30% drop in April plasma collections and is now preserving cash, but Wall Street analysts see a few upcoming growth drivers.
By Nick Paul Taylor • June 4, 2020 -
J&J, Takeda cancel $400M surgical patch deal after antitrust scrutiny
U.S. and EU regulators raised concerns over lack of competition in the market for the fibrin sealant products meant to stop bleeding during surgery.
By Susan Kelly • April 13, 2020 -
OrthoPediatrics buys FDA-approved scoliosis tech, challenging Zimmer for market
OrthoPediatrics scooped up ApiFix's minimally invasive deformity correction system, an alternative to spinal fusion procedures and Zimmer Biomet's vertebral body tethering technology.
By Maria Rachal • April 2, 2020 -
Exact Sciences closes takeovers of 2 cancer testing businesses
The deals give the diagnostics company a solid tumor test and R&D capabilities as it aims to expand beyond its flagship Cologuard product.
By Nick Paul Taylor • March 4, 2020 -
After waffling, Qiagen agrees to $11.5B buyout by Thermo Fisher
Months of will-they-won't-they M&A rumors culminated in the Dutch test maker accepting an offer for a 23% premium on its shares, as Thermo Fisher aims to strengthen its molecular diagnostics and infectious disease efforts.
By Maria Rachal • March 3, 2020 -
Teleflex strikes $260M deal, gaining parts used in TAVR procedures
In releasing quarterly results, the Wayne, Pennsylvania-based medtech also gave updates on a new direct-to-consumer ad campaign and headwinds expected from the coronavirus outbreak.
By Nick Paul Taylor • Feb. 20, 2020 -
Private equity medical practice takeovers more than doubled from 2013 to 2016
Heart, eye and radiology medical practices were among the increasingly attractive targets, according to research published in JAMA.
By Samantha Liss • Feb. 19, 2020 -
Medtronic buys British surgical AI company, adding to Hugo robot effort
The acquisition of Digital Surgery comes as Medtronic inches its own soft tissue robot toward competition with Intuitive's da Vinci.
By Maria Rachal • Feb. 13, 2020 -
Intuitive buys IT startup for surgical video sharing, archiving, analysis
The acquisition of clinical video and image documentation company Orpheus Medical comes as big players like J&J and Medtronic are preparing to shake up the robotic surgery market.
By Maria Rachal • Feb. 11, 2020 -
Qiagen, still independent, limps back from 2019
The Dutch maker of infectious disease instruments and consumables is seeking a rebound, with an early boost from coronavirus-driven demand. Cowen analysts noted the firm beat expectations but added: "The bar was quite low."
By Nick Paul Taylor • Feb. 5, 2020 -
Smith & Nephew acquires Tusker's PMA-winning ear infection device for ENT portfolio
The buyout of Tusker Medical comes two months after it won FDA premarket approval for an ear tube delivery system that can be used in young children with local anesthesia alone in a doctor's office.
By Maria Rachal • Jan. 24, 2020 -
Medical device sales flat, J&J CEO promises big year for robots
A Medical Device Business Review Day scheduled for this spring in New York City will feature "tangible evidence of not only the machines, but also the digital platform component," Alex Gorsky said of J&J's robotic surgery ventures.
By Nick Paul Taylor • Updated Jan. 23, 2020 -
Quest buys Helsinki-based Blueprint Genetics to expand reach
Blueprint Genetics sells 3,900 targeted single gene and more than 200 panel tests for conditions spanning 14 medical specialties. Financial terms of the all-cash equity deal were not disclosed.
By Rebecca Pifer • Jan. 22, 2020 -
Health IT to lead 2020 deals, KPMG predicts
The repeal of the medical device tax could boost investor interest in hot areas like non-invasive diagnostics, robotic surgery and AI-enabled devices, although health IT, pharma and biotech appear to be drawing more excitement.
By Linda Wilson • Jan. 15, 2020 -
LabCorp, Quest push for M&A-driven growth despite difficulties closing deals
“It’s still a very fragmented marketplace,” said Quest CEO Steve Rusckowski at JPM. "Trying to get people to move fast has been harder than I would have anticipated,” LabCorp's new CEO Adam Schechter told investors.
By Nick Paul Taylor • Jan. 15, 2020 -
RTI Surgical inks $490M deal to sell OEM unit to private equity
The divestiture will turn Michigan-based RTI into a pure play spine company with up to $200 million in cash, as private equity groups show growing interest in the medical technology sector.
By Nick Paul Taylor • Jan. 14, 2020 -
Medtronic buys new spinal cord tech to boost pain therapies unit
Amid a broader slowdown in the spinal cord stimulation market, Medtronic is acquiring technology from Stimgenics that offers a new way of programming its Intellis implant.
By Maria Rachal • Jan. 9, 2020 -
Digital health M&A flatlines in 2019, but IPO activity promising
Rock Health sees creation of remote patient monitoring reimbursement codes, progress on data blocking rules and FDA's Pre-Cert program as potential growth catalysts for the sector.
By Nick Paul Taylor • Jan. 8, 2020 -
OrthoPediatrics sells Vilex assets in preparation for more M&A
The device maker sold the adult piece of the Vilex business, which it acquired last year, for $25 million.
By Nick Paul Taylor • Jan. 7, 2020 -
Illumina scraps $1.2B PacBio takeover amid regulatory pushback
Cowen analysts listed Agilent, Danaher and Thermo Fisher as potential buyers of Pacific Biosciences.
By Nick Paul Taylor • Jan. 3, 2020 -
FTC slaps Stryker, Wright Medical with second request
In a second amendment to its tender offer statement for Wright Medical, Stryker acknowledged a Wright shareholder's class action lawsuit alleging Wright's solicitation statement was false and misleading.
By David Lim , Maria Rachal • Updated Jan. 23, 2020 -
Wright Medical filings, report hint of rivals to Stryker's $5.4B acquisition
Regulatory filings show as many as five parties besides Stryker, which agreed to pay $30.75 per share, were interested in bidding for Wright.
By Maria Rachal • Dec. 20, 2019 -
J&J takes over Verb Surgical as Verily exits robotics partnership
The move comes four years after J&J launched the venture with Google-backed Verily, further signaling the medtech giant's play for the digital surgery market after its $3.4 billion acquisition of Auris Health.
By Maria Rachal • Dec. 20, 2019 -
Delaware court deals blow to Boston Scientific in Channel Medsystems lawsuit
Boston Scientific's attempt to terminate its $275 million acquisition of cryoablation device maker Channel Medsystems was ruled inappropriate by the Delaware Court of Chancery Wednesday.
By David Lim • Dec. 19, 2019 -
Fujifilm announces delay to $1.63B buyout of Hitachi's diagnostic imaging arm
Citing COVID-19's impacts as a source of slowdown, Fujifilm said the deal is no longer expected to close in July.
By Maria Rachal • Updated May 28, 2020